Graves Gilbert Clinic

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease2 trials
• Rheumatoid arthritis2 trials
• Familial hypercholesterolaemia1 trial
• Prostate cancer1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting2 trials

Lead sponsor

• Amgen1 trial
• Eli Lilly and Company1 trial
• Janssen Research & Development, LLC1 trial
• Novartis Pharmaceuticals1 trial
• Sequenom, Inc.1 trial
• and 1 more

Running trials

• Recruiting

  Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

  NCT07543757· Sequenom, Inc.· Source

  Contact: Christian Jones

• Recruiting

  OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  NCT07136012· Phase 3· Amgen· Source

• Active, not recruiting

  A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

  NCT06671496· Phase 3· Takeda· Source

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Completed

  A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

  NCT06028438· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  A Study of Baricitinib in Participants With Rheumatoid Arthritis

  NCT04086745· Phase 4· Eli Lilly and Company· Source